Howard County Economic Development Authority Launches Minority Owned Business Directory
Looking to support a local, minority-owned business in your neighborhood? ...
Marriott International announces leadership changes
Bill Marriott plans to retire in May as executive chairman of Marriott International Inc. and will not stand for reelection to the board, decades after he guided what was once a family-run root beer stand into one of the world’s largest hospitality companies. ...
FITCI Startup U Series class on Positioning and Messaging with Whitney Hahn
The Frederick Innovative Technology Center, Inc. (FITCI) invites emerging entrepreneurs to a two-hour online workshop on March 7th, 2022. The class focuses on defining a growing business’s positioning and messaging perspective, two essential components in creating an effective business plan. ...
Immunomic Therapeutics Announces Clinical Trial of ITI-3000 for the Treatment of Merkel Cell Carcinoma
February 07, 2022 01:48 PM Eastern Standard Time
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein) -mediated nucleic acid-based immunotherapy, today announced its first Phase 1 clinical study evaluating ITI-3000 in patients with Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer that is typically caused by the Merkel cell polyomavirus (MCPyV). The single-center study will be conducted at the University of Washington School of Medicine and the Fred Hutchinson Cancer Center in Seattle, Washington and will be led by Drs. Paul Nghiem, Song Park and David Koelle. ...
Bloom Energy Announces Fourth Quarter 2021 and Full Year 2021 Financial Results and Updates Long-term Growth Prospects
SAN JOSE, Calif., February 10, 2022–(BUSINESS WIRE)–Bloom Energy Corporation (NYSE: BE) today announced financial results for its fourth quarter ended December 31, 2021. ...
FITCI member iyotee Secures $9.35 Million In Series A Funding and Launches KnowledgeNet.ai
New AI-Driven Network Collaboration App Revolutionizes How Organizations Use Their Intellectual Capital ...
American Gene Technologies’ HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patients
ROCKVILLE, MD. (PRWEB) FEBRUARY 02, 2022 ...
MaxCyte Signs Strategic Platform License with Intima Bioscience to Advance Tumor Infiltrating Lymphocytes Programs
Intima Bioscience to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its solid tumor cell-therapy candidates
NEW YORK and GAITHERSBURG, Md., Jan. 31, 2022 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT, MXCN), a leading provider of enabling platform technologies for ex-vivo cell engineering, today announces the signing of a strategic platform license (SPL) with Intima Bioscience, Inc., a clinical stage biotechnology company developing genetically engineered cell therapies for solid tumor cancer. Intima joins a group of 15 other leading cell therapy companies who have partnered with MaxCyte. ...
Altimmune Announces FDA Clearance Of Pemvidutide (ALT-801) IND For Obesity
January 31, 2022 at 7:00 AM EST ...
USP and WHO Renew Official Relations to Continue Strengthening the Global Medicines Supply Chain
On Saturday, January 29, the World Health Organization (WHO) Executive Board approved the renewal of official relations with the United States Pharmacopeial Convention (USP) through 2023. As an independent, scientific nonprofit organization focused on building trust in the supply of safe, quality medicines, USP is honored to continue our longstanding partnership with the WHO and contribute our expertise to shape and advance policies and strategies to improve the health and wellbeing of people around the world. ...